For the year ending 2025-12-31, AURA has $169,430K in assets. $32,517K in debts. $59,515K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 59,515 | |||
| Marketable securities | 84,726 | |||
| Prepaid expenses and other current assets | 5,498 | |||
| Total current assets | 149,739 | |||
| Restricted cash and deposits | 768 | |||
| Right of use assets - operating lease | 15,828 | |||
| Other long-term assets | 471 | |||
| Property and equipment, gross | 9,676 | |||
| Lessaccumulated depreciation | 7,052 | |||
| Property and equipment, net | 2,624 | |||
| Total assets | 169,430 | |||
| Accounts payable | 1,549 | |||
| Short-term operating lease liability | 3,243 | |||
| Accrued expenses and other current liabilities | 13,591 | |||
| Total current liabilities | 18,383 | |||
| Long-term operating lease liability | 14,134 | |||
| Total liabilities | 32,517 | |||
| Additional paid-in capital | 617,433 | |||
| Accumulated deficit | -480,418 | |||
| Accumulated other comprehensive income (loss) | -102 | |||
| Total stockholders' equity | 136,913 | |||
| Total liabilities and stockholders' equity | 169,430 | |||
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)